Related Experiment Video
Updated: Aug 15, 2026
06:58
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Aggressive Risk Factor Management in the Elderly: Are You Ever Too Old?
1Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO.
The American Journal of Geriatric Cardiology
|June 21, 2001
Summary
Smoking cessation and hypertension management are crucial for reducing cardiovascular disease risk in older adults. Treating high cholesterol also benefits older individuals, though treatment for those over 80 requires individual consideration.
Area of Science:
- Cardiology
- Geriatrics
- Public Health
Background:
- Cardiovascular disease (CVD) is a major health concern in older adults.
- Smoking, hypertension, and hyperlipidemia are key modifiable risk factors for CVD.
Purpose of the Study:
- To review the impact of smoking, hypertension, and hyperlipidemia on cardiovascular disease in the elderly.
- To provide recommendations for managing these risk factors in older populations.
Main Methods:
- Literature review of clinical trials and epidemiological data.
- Analysis of risk factor prevalence and impact across different age groups.
Main Results:
- Smoking cessation rapidly reduces CVD risk in the elderly.
- Blood pressure reduction effectively lowers CVD risk, even in individuals up to 90 years old.
- Cholesterol reduction improves outcomes in those over 75, but treatment for those over 80 needs individualization.
Conclusions:
- Aggressive smoking cessation promotion is recommended for all ages.
- Treatment of both systolic and diastolic hypertension is strongly advised regardless of age.
- Hyperlipidemia management in the very elderly (over 80) requires personalized therapeutic strategies.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...